Literature DB >> 20493462

Migraine headache and ischemic stroke risk: an updated meta-analysis.

June T Spector1, Susan R Kahn, Miranda R Jones, Monisha Jayakumar, Deepan Dalal, Saman Nazarian.   

Abstract

BACKGROUND: Observational studies, including recent large cohort studies that were unavailable for prior meta-analysis, have suggested an association between migraine headache and ischemic stroke. We performed an updated meta-analysis to quantitatively summarize the strength of association between migraine and ischemic stroke risk.
METHODS: We systematically searched electronic databases, including MEDLINE and EMBASE, through February 2009 for studies of human subjects in the English language. Study selection using a priori selection criteria, data extraction, and assessment of study quality were conducted independently by reviewer pairs using standardized forms.
RESULTS: Twenty-one (60%) of 35 studies met the selection criteria, for a total of 622,381 participants (13 case-control, 8 cohort studies) included in the meta-analysis. The pooled adjusted odds ratio of ischemic stroke comparing migraineurs with nonmigraineurs using a random effects model was 2.30 (95% confidence interval [CI], 1.91-2.76). The pooled adjusted effect estimates for studies that reported relative risks and hazard ratios, respectively, were 2.41 (95% CI, 1.81-3.20) and 1.52 (95% CI, 0.99-2.35). The overall pooled effect estimate was 2.04 (95% CI, 1.72-2.43). Results were robust to sensitivity analyses excluding lower quality studies.
CONCLUSIONS: Migraine is associated with increased ischemic stroke risk. These findings underscore the importance of identifying high-risk migraineurs with other modifiable stroke risk factors. Future studies of the effect of migraine treatment and modifiable risk factor reduction on stroke risk in migraineurs are warranted. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20493462      PMCID: PMC2900472          DOI: 10.1016/j.amjmed.2009.12.021

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  57 in total

1.  Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III.

Authors: 
Journal:  Stroke       Date:  1990-04       Impact factor: 7.914

2.  Lifestyle-associated risk factors for acute brain infarction among persons of working age.

Authors:  H Haapaniemi; M Hillbom; S Juvela
Journal:  Stroke       Date:  1997-01       Impact factor: 7.914

3.  Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline.

Authors:  Larry B Goldstein; Robert Adams; Mark J Alberts; Lawrence J Appel; Lawrence M Brass; Cheryl D Bushnell; Antonio Culebras; Thomas J Degraba; Philip B Gorelick; John R Guyton; Robert G Hart; George Howard; Margaret Kelly-Hayes; J V Ian Nixon; Ralph L Sacco
Journal:  Stroke       Date:  2006-05-04       Impact factor: 7.914

4.  Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

Authors:  Donald Lloyd-Jones; Robert Adams; Mercedes Carnethon; Giovanni De Simone; T Bruce Ferguson; Katherine Flegal; Earl Ford; Karen Furie; Alan Go; Kurt Greenlund; Nancy Haase; Susan Hailpern; Michael Ho; Virginia Howard; Brett Kissela; Steven Kittner; Daniel Lackland; Lynda Lisabeth; Ariane Marelli; Mary McDermott; James Meigs; Dariush Mozaffarian; Graham Nichol; Christopher O'Donnell; Veronique Roger; Wayne Rosamond; Ralph Sacco; Paul Sorlie; Randall Stafford; Julia Steinberger; Thomas Thom; Sylvia Wasserthiel-Smoller; Nathan Wong; Judith Wylie-Rosett; Yuling Hong
Journal:  Circulation       Date:  2008-12-15       Impact factor: 29.690

Review 5.  Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century.

Authors:  Valery L Feigin; Carlene M M Lawes; Derrick A Bennett; Craig S Anderson
Journal:  Lancet Neurol       Date:  2003-01       Impact factor: 44.182

6.  Endothelin 1 in migraine and tension-type headache.

Authors:  V Gallai; P Sarchielli; C Firenze; A Trequattrini; M Paciaroni; F Usai; R Palumbo
Journal:  Acta Neurol Scand       Date:  1994-01       Impact factor: 3.209

Review 7.  Stroke in pregnancy.

Authors:  Steven K Feske
Journal:  Semin Neurol       Date:  2007-11       Impact factor: 3.420

Review 8.  Recognition and treatment of menstrual migraine.

Authors:  Christine L Lay; Richard Payne
Journal:  Neurologist       Date:  2007-07       Impact factor: 1.398

9.  Etiology of and risk factors for cerebral infarction in young adults in western Norway: a population-based case-control study.

Authors:  H Naess; H I Nyland; L Thomassen; J Aarseth; K-M Myhr
Journal:  Eur J Neurol       Date:  2004-01       Impact factor: 6.089

Review 10.  Migraine prevalence. A review of population-based studies.

Authors:  W F Stewart; A Shechter; B K Rasmussen
Journal:  Neurology       Date:  1994-06       Impact factor: 9.910

View more
  99 in total

Review 1.  Hormonal contraception and migraine: clinical considerations.

Authors:  Stephanie S Faubion; Petra M Casey; Lynne T Shuster
Journal:  Curr Pain Headache Rep       Date:  2012-10

2.  Statins for all: should patients who have migraine with aura be on a statin?

Authors:  David Kernick
Journal:  Br J Gen Pract       Date:  2015-11       Impact factor: 5.386

3.  Higher augmentation index is associated with tension-type headache and migraine in middle-aged/older humans with obesity.

Authors:  Graziela Z Kalil; Ana Recober; Ann Hoang-Tienor; Miriam Bridget Zimmerman; William G Haynes; Gary L Pierce
Journal:  Obesity (Silver Spring)       Date:  2016-02-05       Impact factor: 5.002

4.  Are migraine and non-migrainous headache risk factors for stroke in the elderly? Findings from a 12-year cohort follow-up.

Authors:  J Norton; F Portet; A Gabelle; S Debette; K Ritchie; J Touchon; C Berr
Journal:  Eur J Neurol       Date:  2016-07-11       Impact factor: 6.089

5.  Fasting lipid and lipoproteins concentrations in pregnant women with a history of migraine.

Authors:  Bizu Gelaye; Gloria T Larrabure-Torrealva; Chunfang Qiu; Miguel Angel Luque-Fernandez; B Lee Peterlin; Sixto E Sanchez; Michelle A Williams
Journal:  Headache       Date:  2015-04-22       Impact factor: 5.887

6.  Stroke and Stroke-Like Symptoms in Patients with Mutations in the POLG1 Gene.

Authors:  Waleed Brinjikji; Jerry W Swanson; Carrie Zabel; Peter J Dyck; Jennifer A Tracy; Ralitza H Gavrilova
Journal:  JIMD Rep       Date:  2011-06-22

7.  Migraine and subclinical atherosclerosis: endothelial dysfunction biomarkers and carotid intima-media thickness: a case-control study.

Authors:  Aynur Yilmaz Avci; Mehmet Husamettin Akkucuk; Ebru Torun; Serap Arikan; Ufuk Can; Mustafa Agah Tekindal
Journal:  Neurol Sci       Date:  2019-01-15       Impact factor: 3.307

Review 8.  Ischaemic stroke in young adults: risk factors and long-term consequences.

Authors:  Noortje A M M Maaijwee; Loes C A Rutten-Jacobs; Pauline Schaapsmeerders; Ewoud J van Dijk; Frank-Erik de Leeuw
Journal:  Nat Rev Neurol       Date:  2014-04-29       Impact factor: 42.937

9.  Transient ischemic attack requiring hospitalization of children in the United States: kids' inpatient database 2003 to 2009.

Authors:  Malik M Adil; Adnan I Qureshi; Lauren A Beslow; Lori C Jordan
Journal:  Stroke       Date:  2014-02-12       Impact factor: 7.914

Review 10.  Estrogen, migraine, and vascular risk.

Authors:  Gianni Allais; Giulia Chiarle; Silvia Sinigaglia; Gisella Airola; Paola Schiapparelli; Chiara Benedetto
Journal:  Neurol Sci       Date:  2018-06       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.